Brief: ProQR Therapeutics Files Prospectus Related To Resale Of Up To 3.99 Mln Of Ordinary Shares By Selling Shareholders
Nov 17 (Reuters) - ProQR Therapeutics NV PRQR.O :
* PROQR THERAPEUTICS FILES PROSPECTUS RELATED TO RESALE OF
UP TO
3.99 MILLION OF ORDINARY SHARES BY THE SELLING SHAREHOLDERS -
SEC FILING
Further company coverage: PRQR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview